|Articles|September 1, 2011
- Pharmaceutical Executive-09-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - September 2011
From Many, One
Advertisement
Articles in this issue
almost 15 years ago
Pharm Exec's 10th Annual Industry Auditalmost 15 years ago
Pharma and Social Media: Ready to Make Nice?almost 15 years ago
The Power of Product Development Partnershipalmost 15 years ago
Front and Center in the Fight against TBalmost 15 years ago
How to Recruit 70,000 People in One Yearalmost 15 years ago
Innovating Around Innovationalmost 15 years ago
India: Good Endings, Good Beginnings!almost 15 years ago
Two Million Man Hoursalmost 15 years ago
Rebates and Reformalmost 15 years ago
Should the US Gamble with Risk Sharing?Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5